跳至主要内容
临床试验/CTRI/2022/01/039577
CTRI/2022/01/039577已完成4 期

CLINICAL EVALUATION OF EFFICACY AND LONGEVITY OF NANOSEAL AND ADMIRA PROTECT DESENSITIZING AGENTS ON REDUCING DENTINE HYPERSENSITIVITY AFTER SINGLE DOSE APPLICATION.A RANDOMIZED, SPLIT MOUTH CLINICAL TRIAL.

ESWARI PRIYA GUMMADI0 个研究点目标入组 55 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
55

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients with age ranged from 18-50 years, with the presence of at least 1 sensitive molar each, in at least two quadrants, with a Schiff cold air sensitivity score of >=2 on occlusal surfaces of attrited molars, that are not going to be planned to receive any restorations are going to be included in the study.

排除标准

  • Patients who are already using desensitizing agents, teeth with Abrasions, Erosions, Cracked enamel, Carious lesions, Defective restorations, Pathology of pulp.
  • Patients with active Periodontal disease and patients using medication with analgesic drugs.
  • Pregnant or lactating women, and patients with eating disorders and regurgitation or chronic diseases are going to be excluded from the study.

研究者

发起方
ESWARI PRIYA GUMMADI

相似试验

Comparing two different desensitizing agents after... | 临床试验